Technical Analysis for AKTX - Akari Therapeutics Plc

Grade Last Price % Change Price Change
F 1.8 0.00% 0.00
AKTX closed unchanged on Thursday, May 13, 2021, on 25 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down
Historical AKTX trend table...

Date Alert Name Type % Chg
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
Narrow Range Bar Range Contraction 0.00%
NR7 Range Contraction 0.00%
NR7-2 Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
NR7 Range Contraction -4.76%
Wide Bands Range Expansion -4.76%
Oversold Stochastic Weakness -4.76%
Older End-of-Day Signals for AKTX ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Up 3% about 8 hours ago
Down 2 % about 8 hours ago
Down 1% about 8 hours ago
60 Minute Opening Range Breakdown about 9 hours ago
Fell Below Previous Day's Low about 9 hours ago
View Earlier Intraday Alerts

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Akari Therapeutics Plc Description

Akari Therapeutics, Plc is a clinical-stage biopharmaceutical company that focuses on the development and commercialization of therapeutics to treat rare and orphan autoimmune and inflammatory diseases. The company develops Coversin, a second-generation complement inhibitor that acts on complement component-C5, preventing release of C5a and formation of C5b – 9 (membrane attack complex or MAC). It develops products to treat rare diseases, such as paroxysmal nocturnal haemoglobinuria (PNH), atypical hemolytic uremic syndrome (aHUS), myasthenia gravis (MG), Guillain Barré syndrome (GBS), and Sjögren's syndrome. The company was formerly known as Volution Immuno Pharmaceuticals SA and changed its name to Akari Therapeutics, Plc in September 2015. The company is based in New York, New York. Akari Therapeutics, Plc operates as a subsidiary of RPC Pharma Limited.


Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biopharmaceutical Organ Systems Rare Diseases Inflammatory Disease Inflammatory Diseases Autoimmunity Autoimmune And Inflammatory Diseases Autoimmune And Inflammatory Disease Complement System Hemoglobinuria Myasthenia Myasthenia Gravis Paroxysmal Nocturnal Hemoglobinuria Acquired Hemolytic Anemia Hemolytic Uremic Syndrome Pnh Atypical Hemolytic Uremic Syndrome C5a Sjögren's Syndrome

Is AKTX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 4.21
52 Week Low 1.42
Average Volume 521,459
200-Day Moving Average 2.15
50-Day Moving Average 2.47
20-Day Moving Average 2.11
10-Day Moving Average 1.90
Average True Range 0.19
ADX 13.67
+DI 18.21
-DI 19.18
Chandelier Exit (Long, 3 ATRs ) 2.18
Chandelier Exit (Short, 3 ATRs ) 2.31
Upper Bollinger Band 2.59
Lower Bollinger Band 1.64
Percent B (%b) 0.17
BandWidth 45.02
MACD Line -0.19
MACD Signal Line -0.18
MACD Histogram -0.0135
Fundamentals Value
Market Cap 69.25 Million
Num Shares 38.5 Million
EPS -0.87
Price-to-Earnings (P/E) Ratio -2.06
Price-to-Sales 0.00
Price-to-Book 18.09
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.96
Resistance 3 (R3) 1.96 1.91 1.94
Resistance 2 (R2) 1.91 1.87 1.91 1.93
Resistance 1 (R1) 1.86 1.85 1.83 1.85 1.92
Pivot Point 1.80 1.80 1.79 1.80 1.80
Support 1 (S1) 1.75 1.76 1.72 1.75 1.68
Support 2 (S2) 1.70 1.74 1.70 1.67
Support 3 (S3) 1.64 1.70 1.67
Support 4 (S4) 1.64